Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Companyâs intellectual portfolio consists of 19 patent families including 31 granted patents.
äŒæ¥ã³ãŒãCMND
äŒç€ŸåClearmind Medicine Inc
äžå Žæ¥Aug 10, 2021
æé«çµå¶è²¬ä»»è
ãCEOãZuloff-Shani (Adi)
åŸæ¥å¡æ°- -
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Aug 10
æ¬ç€Ÿæåšå°101-1220 West 6Th Avenue
éœåžVANCOUVER
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœCanada
éµäŸ¿çªå·V6H 1A5
é»è©±çªå·16042601566
ãŠã§ããµã€ãhttps://www.clearmindmedicine.com/
äŒæ¥ã³ãŒãCMND
äžå Žæ¥Aug 10, 2021
æé«çµå¶è²¬ä»»è
ãCEOãZuloff-Shani (Adi)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã